Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature-Reference-Cited by-同舟云学术

Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature

Published:2022-03 Issue: Volume:37 Page:27-35
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Geertsen Louise^ORCID,Koldby Kristina Magaard,Thomassen Mads,Kruse Torben,Lund Lars

Publisher

Elsevier BV

Subject

Urology

Reference35 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Ljungberg B, Albiges L, Bensalah K, et al. EAU guidelines: renal cell carcinoma 2020 V3-1. Arnhem, The Netherlands: European Association of Urology; 2020. https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Renal-Cell-Carcinoma-2020V3.pdf.

3. Danske Multidisciplinære Cancer Grupper. Renalcellecarcinomer – patologi. https://www.dmcg.dk/siteassets/forside/kliniske-retningslinjer/godkendte-kr/darenca/darenca_patologi_adm-godk_jbh100919.pdf.

4. Genetics and epigenetics of renal cell cancer;Baldewijns;Biochim Biophys Acta,2008

5. Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies;Ellinger;Urologe A,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Turning the tide: pembrolizumab’s triumph in adjuvant RCC therapy;Medical Oncology;2024-09-05

2. Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic Review;Kidney Cancer;2024-08-07

3. Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma;The Oncologist;2024-07-16

4. Une nouvelle place pour les biomarqueurs circulants dans le cancer du rein en 2024 ?;Bulletin du Cancer;2024-06

5. Anti-VEGF and -PD-1 Combinations in Renal Cell Carcinoma: When Are Treatment Breaks Safe?;European Urology;2024-06